Follow-The-Filings

Security

COLL

Collegium Pharmaceutical Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

12 owners 1 new max 0.8% (Third Avenue Management LLC)

grid → activity →
owners 12
max % 0.8%
tracked value $246M
qoq N 1 A 5 R 4

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Third Avenue Management LLC 2026 Q1 0.8% Reduce -0.88 pp 155,143 $5M hist
Renaissance Technologies LLC 2026 Q1 0.1% Reduce -0.04 pp 1,469,449 $49M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 748,812 $25M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit -0.02 pp 366,099 $17M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce -0.01 pp 530,698 $18M hist
Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 55,614 $2M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 2,256,254 $104M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 360,826 $12M hist
Norges Bank 2025 Q4 stale 0.0% Exit 0.00 pp 112,500 $5M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 135,216 $4M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 121,366 $4M hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% New 0.0% 27,039 $894 hist

12 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $144.77M $144.92M $177.76M
Gross profit $77.4M $91.46M $97.32M
Gross margin * 53.5% 63.1% 54.8%
Net income -$17.43M $27.71M $2.42M
Net margin * -12.0% 19.1% 1.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $537.6M $482.26M $691.41M
Total non-current assets * $605.71M $1.18B $965.42M
Total assets $1.14B $1.66B $1.66B
Total current liabilities $457.92M $509.51M $440.03M
Total non-current liabilities * $489.96M $925.24M $915.13M
Total equity $195.43M $228.84M $301.68M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $274.75M $204.98M $329.32M
Cash from investing -$70.81M -$287.76M -$63.53M
Cash from financing -$140.18M -$60.6M -$110.24M
Net change in cash * $63.76M -$143.38M $155.55M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders